GENE ONLINE|News &
Opinion
Blog

Aduhelm
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
Aftermath of Biogen’s Alzheimer’s Drug Approval Continues as Some Hospitals, Insurers Refuse Administration
2021-07-18
Biogen’s Controversial Alzheimer’s Drug Wins Historic FDA Approval
2021-06-07
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top